SCHEMBL2964502

SCHEMBL2964502

COC(=O)CCc1cc(C(=O)O)ccc1OCC(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOS P01100 2/20 0.60
JUN P05412 2/20 0.60
ALDH1A1 P00352 2/20 0.49
HIF1A Q16665 1/20 0.49
LTB4R Q15722 1/20 0.46
TSHR P16473 2/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
MYC P01106 2/20 0.44
MAX P61244 2/20 0.44
EP300 Q09472 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
XDH P47989 1/20 0.42
AKR1C3 P42330 1/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4280457 0.91 FOS (0.60) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL27594611 0.89 FOS (0.59) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL2958785 0.88 FOS (0.58) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4281322 0.87 ALDH1A1 (0.51) FOSJUNALDH1A1HIF1ATSHR
SCHEMBL4284195 0.83 FOS (0.64) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4291411 0.80 FOS (0.55) FOSJUNALDH1A1HIF1ATSHR
SCHEMBL4277010 0.80 JUN (0.61) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4288990 0.80 JUN (0.73) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL2958810 0.79 FOS (0.53) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL27908941 0.78 FOS (0.56) FOSJUNALDH1A1HIF1AXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445249-B1 NOVEL BENSOPHENONE DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-07 EP disclosed
US-7772285-B2 Benzophenone derivatives or salts thereof TOYAMA CHEMICAL CO., LTD. (JP) 2010-08-10 US disclosed
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SHUNICHI SHIOZAWA (JP) 2005-05-26 US disclosed
EP-1445249-A1 NOVEL BENSOPHENONE DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113400-A1 Inhibitors of transcription factor AP-1; autoimmune diseases; rheumatoid arthritis; high safety and excellent pharmacokinetics in vivo SP1, AP1G1, JUN FOS 163/4885JUN 3/4885ALDH1A1 1493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.